发布时间:2019-08-03 23:43 原文链接: Stathminandbreastcancerresistancetoantimicrotubuleagents

Stathmin is a ubiquitous, cytosolic 19-kDa protein, which is phosphorylated on up to four sites in response to many regulatory signals within cells. Its molecular characterization indicates a functional organization including an N-terminal regulatory domain that bears the phosphorylation sites, linked to a putative alpha-helical binding domain predicted to participate in coiled-coil, protein-protein interactions. In addtion to the protein kinases that phospjhorylate Stathmin such as CaMK, MAPK, p34cdc2, PKA, a few other proteins have been suggested to interact with stathmin in vivo. One of them was identified as BiP, a member of the hsp70 heat-shock protein family. Another is a previously unidentified, putative serine/threonine kinase, KIS, which might be regulated by stathmin or, more likely, be part of the kinases controlling its phosphorylation state. Finally, two proteins, CC1 and CC2, predicted to form alpha-helices participating in coiled-coil interacting structures. It has been also suggest that the action of antimicrotubule drugs can be affected by stathmin in at least two ways: (a) altered drug binding; and (b) growth arrest at the G2 to M boundary. Mutant p53 breast cancers exhibiting high levels of stathmin may be resistant to antimicrotubule agents.

Contributor: Kosi Gramatikoff, PhD

REFERENCES: Elizabeth Alli, Judy Bash-Babula, Jin-Ming Yang and William N. Hait Effect of Stathmin on the Sensitivity to Antimicrotubule Drugs in Human Breast CancerCancer Research 62, 6864-6869, December 1, 2002 Manceau V, Gavet O, Curmi P, Sobel A. Stathmin interaction with HSC70 family proteins. Electrophoresis. 1999 Feb;20(2):409-17. Maucuer A, Camonis JH, Sobel A. Stathmin interaction with a putative kinase and coiled-coil-forming protein domains. Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3100-4. Maucuer A, Le Caer JP, Manceau V, Sobel A. Specific Ser-Pro phosphorylation by the RNA-recognition motif containing kinase KIS. Eur J Biochem. 2000 Jul;267(14):4456-64. Maucuer A, Ozon S, Manceau V, Gavet O, Lawler S, Curmi P, Sobel A. KIS is a protein kinase with an RNA recognition motif. J Biol Chem. 1997 Sep 12;272(37):23151-6. P Amayed et al. The Effect of Stathmin Phosphorylation on Microtubule Assembly Depends on Tubulin Critical Concentration* THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 277, No. 25, Issue of June 21, pp. 22718–22724, 2002


相关文章

美国TO设备助阵,第六届上海市力学竞赛团体赛圆满成功

2024年11月9日,由上海市力学学会主办、同济大学承办的第六届上海市大学生力学竞赛团体赛在同济大学举行。来自同济大学、上海交通大学、复旦大学、华东师范大学、上海大学、上海工程技术大学、上海师范大学、......

NatCancer:科学家有望开发出一种治疗肝癌的新疗法

包括肝脏内胆管癌和肝细胞癌在内的成人肝脏恶性肿瘤是全球癌症相关死亡的第二大原因,大部分的患者都会接受化疗或免疫疗法,或者两种疗法的组合,同时也并没有特定的生物标志物可以选择。近日,一篇发表在国际杂志N......

先发的文章被撤稿!韩志武团队图片使用不当,被撤稿

全世界每年大肠癌(CRC)死亡60万例,但是其潜在的治疗靶标有限。2018年3月25日,青岛大学韩志武团队(其中高慧为共同第一作者,点击阅读)在CancerScience在线发表题为“Hispidul......

CancerRes:皮肤鳞状细胞癌新靶点

皮肤鳞状细胞癌(cuSCC)是美国第二大最常见的恶性肿瘤,每年约有700,000例新病例。累积暴露于紫外线是导致cuSCC的主要环境风险因素。虽然大多数cuSCC病例易于管理和治疗,但一小部分患者对治......

CancerRes:代谢适应性保证癌细胞的存活

p53是细胞生长中最重要的控制蛋白之一,缺乏p53的结肠癌细胞会激活特定的代谢途径以适应肿瘤内部氧和营养的缺乏。正如德国癌症研究中心(DKFZ)的科学家现已发现的那样,通常用来降低胆固醇的他汀类药物会......

惊爆:这篇Nature论文涉嫌近30张图片造假,半年后被撤稿

2019年2月21日,Nature杂志发布了一则撤稿声明,撤回了休斯顿卫理公会医院和贝勒医学院于2018年9月5日发表的题为:AhomingsystemtargetstherapeuticTcells......

CancerRes:维生素D或能有效抑制黑色素瘤的进展

近日,一项刊登在国际杂志CancerResearch上的研究报告中,来自英国癌症研究中心等机构的科学家们通过研究在实验室中发现,维生素D或能通过降低黑色素瘤细胞的侵袭性来影响其行为。研究者发现,维生素......

CancerDiscov循环肿瘤细胞靶向扩散到远端器官的分子机制

很多种癌症都会引发患者死亡,因为肿瘤细胞能离开原发性位点入侵到远端器官中从而引发癌症患者直至其死亡;近日,一项刊登在国际杂志CancerDiscovery上的研究报告中,来自南加州大学的科学家们通过对......

CancerDiscov:循环肿瘤细胞靶向扩散远端器官的分子机制

很多种癌症都会引发患者死亡,因为肿瘤细胞能离开原发性位点入侵到远端器官中从而引发癌症患者直至其死亡;近日,一项刊登在国际杂志CancerDiscovery上的研究报告中,来自南加州大学的科学家们通过对......

CancerRes:科学家们在胰腺癌中发现了“抑癌细胞”

胰腺癌是传统抗癌药物难以治疗的一种癌症。最近,名古屋大学(NagoyaUniversity)的研究者们发现,含有一种名为Meflin的蛋白质的细胞在抑制胰腺癌的恶化中具有重要作用。研究小组还表明,可以......